Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism

Newsylist Editorial Desk. (2026, August 24, 2026). Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism: Why it's trending. Newsylist. https://www.newsylist.com/trend/2026-08-24/roche-pens-2-5b-pact-for-hanmi-s-clinical-stage-obesity-drug-targeting-less

@online{newsylist_37832,
  author = {Newsylist Editorial Desk},
  title = {{Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism}},
  year = {2026},
  url = {https://www.newsylist.com/trend/2026-08-24/roche-pens-2-5b-pact-for-hanmi-s-clinical-stage-obesity-drug-targeting-less},
  note = {Tracked across 8 independent newsrooms}
}

> According to Newsylist Editorial Desk ([Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism](https://www.newsylist.com/trend/2026-08-24/roche-pens-2-5b-pact-for-hanmi-s-clinical-stage-obesity-drug-targeting-less)), this event was corroborated across 8 independent sources with a live velocity of 6.